Tokyo, Oct. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059453) titled 'Tirzepatide's Assessment on Satiety and Treatment Experience' on Oct. 20.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Historical
Primary Sponsor:
Institute - Kimitsu Chuo Hospital
Condition:
Condition - type 2 diabetes mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - evaluating the impact on eating behavior of T2DM patient.
Basic objectives2 - Safety,Efficacy
Intervention:
Interventions/Control_1 - we prescribed self-injection 2.5 mg Tirzepatide per week. T...